GLP-1 Series: Week 5 GLP-1 Side Effects: From Common Symptoms to Serious Risks

GLP-1 medications such as semaglutide and tirzepatide have become widely used for type 2 diabetes and weight management.

Throughout this series, we’ve discussed how these medications work, the importance of protecting muscle during weight loss, and why eating less doesn’t necessarily mean eating better.

For Week 5, we’re focusing on another important part of making an informed healthcare decision:

Side effects and potential risks.

Every medication has potential benefits and risks. GLP-1 medications are no exception.

Some side effects are common and relatively mild. Others are much less common but potentially serious.

The purpose of this article isn’t to promote these medications or frighten people away from them.

It’s to understand what medical research and current prescribing information actually tell us.

The Most Common GLP-1 Side Effects

The most frequently reported adverse effects of GLP-1 receptor agonists involve the gastrointestinal system.

Depending on the specific medication, common symptoms include:

• Nausea

• Vomiting

• Diarrhea

• Constipation

• Abdominal pain

• Indigestion

• Bloating or abdominal distension

• Burping

• Heartburn or reflux

These symptoms are particularly common when treatment begins or the dose is increased.

For many people, gastrointestinal symptoms improve as the body adjusts.

But that doesn’t mean persistent or severe symptoms should automatically be ignored.

Why Do GLP-1 Medications Affect Digestion?

One of the actions of GLP-1 receptor activation is an effect on gastrointestinal motility, including slowing gastric emptying.

In simple terms:

Food can remain in the stomach longer.

That can contribute to increased fullness and reduced food intake, but it can also contribute to nausea, vomiting, abdominal discomfort and other digestive symptoms.

The effect on gastric emptying isn’t necessarily identical throughout treatment. With some long-acting GLP-1 medications, the effect can diminish with continued exposure, although gastrointestinal symptoms can still occur.

Severe Gastrointestinal Problems

Most gastrointestinal side effects are manageable, but severe reactions can occur.

Current prescribing information for medications such as semaglutide and tirzepatide includes warnings about severe gastrointestinal adverse reactions.

These medications are generally not recommended for people with severe gastroparesis.

Gastroparesis is a condition in which the stomach empties abnormally slowly without a mechanical obstruction.

Symptoms can include:

• Feeling full very quickly

• Nausea

• Vomiting

• Bloating

• Abdominal discomfort

• Difficulty eating adequate amounts of food

Persistent or severe gastrointestinal symptoms should be evaluated rather than simply accepted as part of weight loss.

Dehydration and Kidney Problems

Vomiting and diarrhea don’t just make someone uncomfortable.

If they become significant or prolonged, they can cause dehydration.

Severe dehydration can reduce blood flow to the kidneys and contribute to acute kidney injury, particularly in susceptible individuals.

This is why hydration becomes especially important when taking medications that can produce gastrointestinal symptoms.

Persistent vomiting, diarrhea, dizziness, weakness, very low urine output or an inability to keep fluids down deserves medical attention.

Gallstones and Gallbladder Disease

Gallbladder complications are another important part of the GLP-1 conversation.

Research has found an association between GLP-1 receptor agonists and increased risk of gallbladder and biliary disease, including gallstones and inflammation of the gallbladder.

There is an additional complication:

Rapid weight loss itself can increase gallstone risk.

That means gallbladder problems may involve several factors rather than one simple cause.

Symptoms such as persistent upper-right abdominal pain, fever or jaundice should be medically evaluated.

Acute Pancreatitis

Pancreatitis is inflammation of the pancreas.

Cases of acute pancreatitis, including serious forms, have been reported in people taking GLP-1 receptor agonists, and pancreatitis appears in the warnings and precautions for several medications in this class.

Symptoms can include:

Severe, persistent abdominal pain that may radiate into the back, with or without vomiting.

Anyone experiencing symptoms suggestive of pancreatitis needs prompt medical evaluation.

However, an important scientific distinction needs to be made.

The fact that pancreatitis has been reported doesn’t mean researchers have proven that GLP-1 medications commonly cause it.

Clinical trials and meta-analyses have produced somewhat mixed findings regarding whether these medications significantly increase pancreatitis risk.

That’s why pancreatitis remains an area of continued research and monitoring.

We’ll take a much deeper look at GLP-1 medications and the pancreas in Week 6.

Low Blood Sugar

GLP-1 receptor agonists work partly by increasing insulin secretion when blood glucose is elevated.

When used by themselves, they generally have a relatively low risk of severe hypoglycemia.

However, the risk can increase when GLP-1 medications are combined with other glucose-lowering medications, particularly:

Insulin

or

Sulfonylureas

People taking multiple diabetes medications may require medication adjustments by their healthcare provider.

Symptoms of hypoglycemia can include sweating, shaking, weakness, dizziness, confusion and rapid heartbeat.

Diabetic Eye Disease

There is another issue particularly relevant to people with diabetes.

Rapid improvement in blood glucose has sometimes been associated with a temporary worsening of existing diabetic retinopathy.

This phenomenon isn’t unique to GLP-1 medications and has previously been observed with rapid improvements in glucose control from other treatments.

People with diabetes—particularly those who already have diabetic retinopathy—should maintain appropriate eye examinations and discuss significant changes in glucose control with their healthcare providers.

Heart Rate

Some GLP-1 medications have been associated with small increases in resting heart rate.

The clinical importance of this varies by individual and medication.

Anyone experiencing persistent racing heartbeat, palpitations or other concerning cardiovascular symptoms should discuss them with a healthcare professional.

GLP-1 Medications and Surgery

This is a newer area of increased attention.

Because GLP-1 medications can affect gastric emptying, food may remain in the stomach longer than expected in some patients.

During general anesthesia or deep sedation, stomach contents can potentially enter the lungs—a complication known as pulmonary aspiration.

If you’re taking a GLP-1 medication and you’re scheduled for surgery or a procedure requiring sedation, make sure your surgeon, physician and anesthesia team know which medication you’re taking.

Do not independently stop a prescription medication before surgery. Follow the instructions provided by your medical team.

The Thyroid C-Cell Tumor Warning

Some GLP-1 medications carry an FDA boxed warning concerning thyroid C-cell tumors.

This warning needs context.

In animal studies, certain GLP-1 receptor agonists caused thyroid C-cell tumors in rodents.

It remains unknown whether medications such as semaglutide cause thyroid C-cell tumors, including medullary thyroid carcinoma, in humans.

Because of this concern, certain GLP-1 medications are contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Researchers continue to investigate long-term thyroid cancer risk in humans.

A warning based on animal studies isn’t proof that the same cancer occurs in humans.

But it shouldn’t simply be ignored either.

This is exactly why continued long-term research matters.

Side Effect Does Not Always Mean Causation

This is an important distinction whenever we talk about medication safety.

If someone develops a medical condition while taking a medication, it doesn’t automatically mean the medication caused that condition.

Millions of people taking medications will naturally develop unrelated illnesses.

Researchers therefore look at whether a condition occurs more frequently among people receiving a medication than would otherwise be expected.

That requires randomized clinical trials, large observational studies, adverse-event monitoring and sometimes many years of follow-up.

Some safety concerns become stronger as more evidence accumulates.

Others become weaker.

That’s how medicine evolves.

When Should You Contact Your Healthcare Provider?

People taking GLP-1 medications should seek medical guidance for significant or persistent symptoms.

Particularly concerning symptoms can include:

• Severe or persistent abdominal pain

• Abdominal pain radiating into the back

• Repeated vomiting

• Inability to keep fluids down

• Signs of significant dehydration

• Severe allergic reactions

• Persistent upper-right abdominal pain

• Yellowing of the skin or eyes

• Significant vision changes

• A new neck lump, persistent hoarseness or difficulty swallowing

Some of these symptoms can have many causes unrelated to GLP-1 medications.

The point isn’t to diagnose yourself.

The point is not to ignore potentially serious symptoms.

Common Doesn’t Mean Harmless—and Rare Doesn’t Mean Inevitable

Risk needs perspective.

A side effect being listed doesn’t mean everyone taking the medication will experience it.

Likewise, something being uncommon doesn’t mean it isn’t important.

Good healthcare decisions involve understanding:

How likely is this complication?

How serious could it be?

What are my individual risk factors?

What benefit am I receiving from the medication?

What alternatives are available?

Those questions are much more useful than simply labeling a medication “good” or “bad.”

The Bottom Line

GLP-1 medications can cause side effects ranging from relatively common gastrointestinal symptoms to much less common but potentially serious medical complications.

We know considerably more about these medications today than we did when they were first introduced.

But research continues.

As millions more people use newer GLP-1 and dual-incretin medications for longer periods of time, medical researchers will continue gathering information about their long-term benefits and risks.

That’s why education matters.

Know what you’re taking.

Understand why you’re taking it.

Know the potential side effects.

Recognize symptoms that shouldn’t be ignored.

And don’t be afraid to ask your healthcare provider questions.

Taking an active role in your healthcare isn’t being difficult.

It’s being informed.

Coming in Week 6

GLP-1 Medications and the Pancreas

Can GLP-1 medications cause pancreatitis?

Can acute pancreatitis become chronic?

Why is chronic pancreatitis associated with pancreatic cancer?

And what does current research actually tell us about GLP-1 medications and pancreatic cancer risk?

We’ll separate what has been established from what remains uncertain.

This article is intended for education only and does not replace individualized medical advice. Never start, stop or change a prescription medication without consulting your healthcare provider.

Body Blast Fitness Studio

Real Women. Real Lives. Real Results.